Vice Chief of Cardiology and Director of Structural Heart Program
The Erlanger Heart and Lung Institute
Chattanooga, Tennessee, United States
Dr. Coylewright is a research scientist, mentor, and clinical leader in interventional cardiology, and Director of the Structural Heart Program for Erlanger Health System in Chattanooga, TN. As a clinical trialist, she serves as national PI for the interatrial shunt trial, FROST-HF, and is a leader for the moderate aortic stenosis trial, EXPAND TAVR II, as well as additional trials of left atrial appendage closure and transcatheter mitral interventions. As a committed teacher and international speaker, Dr. Coylewright has a clear passion for innovative health care delivery models that place patients at the center: many of her publications focus on shared decision making implementation. Her research also includes a focus on diversity, equity and inclusion, complimenting her role as Vice Chief of Cardiology for Faculty Development within southern Tennessee's only academic cardiovascular program.
Sunday, February 26, 2023
1:30 PM – 5:30 PM ET
Disclosure(s): Boston Scientific: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Edwards Lifesciences: Honoraria (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Honoraria (Ongoing); Occlutech: Honoraria (Ongoing)
Sunday, February 26, 2023
1:30 PM – 2:15 PM ET
Disclosure(s): Boston Scientific: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Edwards Lifesciences: Honoraria (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Honoraria (Ongoing); Occlutech: Honoraria (Ongoing)
Monday, February 27, 2023
1:00 PM – 1:10 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
1:15 PM – 1:25 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
1:30 PM – 1:40 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
1:45 PM – 1:55 PM ET
Disclosure information not submitted.
Tuesday, February 28, 2023
10:42 AM – 11:50 AM ET
Disclosure(s): Boston Scientific: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Edwards Lifesciences: Honoraria (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Honoraria (Ongoing); Occlutech: Honoraria (Ongoing)
Tuesday, February 28, 2023
10:42 AM – 10:50 AM ET
Disclosure(s): Boston Scientific: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Edwards Lifesciences: Honoraria (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Honoraria (Ongoing); Occlutech: Honoraria (Ongoing)
Tuesday, February 28, 2023
11:38 AM – 11:50 AM ET
Disclosure(s): Boston Scientific: Consultant/Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Edwards Lifesciences: Honoraria (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic: Honoraria (Ongoing); Occlutech: Honoraria (Ongoing)